Research and Markets: Respiratory Hypersensitivity - Active Pharmaceutical ...
Respiratory Hypersensitivity-API Insights, 2015 report provides Respiratory Hypersensitivity drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master ...
Business Wire (press release) - Wed, 01 Jul 2015 09:41



Health Beat: Lung disease continues to be a major killer in Yuba-Sutter
Chronic lower respiratory disease, of which COPD is included, and lung cancer are the second and fifth leading causes of death in Yuba County, according to the California Department of Public Health county health status profiles for 2015. ... Similar ...
Appeal-Democrat - Sun, 05 Jul 2015 00:07

The Medicines Company: Federal Circuit Rules Against The Medicines ...
KENGREAL is contraindicated in patients with known hypersensitivity (e.g., anaphylaxis) to cangrelor or any component of the product. ... IONSYS will only be administered to patients in hospitals enrolled in the IONSYS REMS program, the goal of which ...
The Wall Street Transcript - Thu, 02 Jul 2015 11:30

Letters to the editor: June 27
In addition to animal cruelty concerns, some guests have hypersensitivity, asthma and allergies triggered by the dusts, molds and bird dander in feather pillows. Although Marriott currently offers “allergy free” rooms, these ... After Marriott's ...
Journal and Courier - Fri, 26 Jun 2015 17:00

Gov't, landlords urged to control mould
It can cause sensory, neurological, and respiratory health issues. Mould reproduces by producing mould spores. And these mould spores can produce toxic substances called mycotoxins, along ... Similarly, BRI includes diagnosable illnesses whose symptoms ...
BVI Beacon - Wed, 01 Jul 2015 18:52



CSL Behring Receives Positive CHMP Opinion for Respreeza® (human alpha-1 ...
Respreeza® is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients and IgA deficient patients with known antibodies against IgA, due to the risk of severe hypersensitivity and anaphylactic reactions ...
Business Wire (press release) - Sun, 28 Jun 2015 23:56

Egalet Announces Launch of Specialty Pharmaceutical Sales Force
OXAYDO is contraindicated in patients with respiratory depression, paralytic ileus, acute or severe bronchial asthma or hypercarbia, or known hypersensitivity to oxycodone or any components of the product. Respiratory depression is the primary risk of ...
PR Newswire (press release) - Tue, 23 Jun 2015 02:56



Evolocumab Receives Mixed FDA Review
The most common adverse events in the evolocumab group were nasopharyngitis, upper respiratory tract infection, back pain, and nausea. Adverse events of special interest in this population included those common among other lipid-lowering therapies, ...
MedPage Today - Mon, 08 Jun 2015 14:11


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014